Work

Abstract A067: βIII-tubulin is a dual cell therapeutic target in pancreatic cancer and regulates sensitivity to TRAIL through a DR5-dependent mechanism

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.pancreatic25-a067

Authors: Grace Schulstad, John Kokkinos, Janet Youkhana, Aparna S. Raina, Meagan E. Davis, Oliver S.M. Arkell, Keilah Garcia Netto, Cyrille Boyer, David Goldstein, Koroush S. Haghighi, George Sharbeen, Joshua A. McCarroll, Phoebe A. Phillips

Institution: UNSW Sydney

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414580669

Cites:

Cited by:

Related to: